| TRADING CENTER |
| NexMed Granted Continued Listing on NASDAQ - Business Wire | |
| NexMed, Inc. Leases Its Facility in New Jersey - Business Wire | |
| NexMed Closes Acquisition of Bio-Quant - Business Wire | |
| Beacon Equity Issues Technical Trading Overview for NexMed Inc. - GlobeNewswire |
| Last trade | Change/%change | P/E ratio | ||
|---|---|---|---|---|
| JNJ | Johnson & Johnson | 64.70 | 0.13 / 0.20% | 14.13 |
| PFE | Pfizer Inc | 18.60 | 0.02 / 0.11% | 15.63 |
| NVS | Novartis AG | 54.84 | 0.24 / 0.44% | 15.40 |
| 2008 Revenue: | $6.0 M | Headquarters: East Windsor, NJ |
| Employees: | 13 | CEO: Dr. Bassam B. Damaj, Ph.D. |
| Net Income: | $-5,171,000.0 | Industry: Pharmaceuticals |
| Market Cap: | $30.2 M | Website: www.nexmed.com |
| Symbol | Price | Change/%Change | Prev. close | High | Low | Last Update | More Info |
|---|---|---|---|---|---|---|---|
| NEXM | 0.32 | -0.00 / -0.94% | 0.32 | 0.34 | 0.32 | Profile Chart News |